Stay updated on ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.
Latest updates to the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference0.7%
- Check15 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.7%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check50 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check57 days agoChange DetectedA new study has been added for the MRI & Radiology Center of Plantation, increasing the total to 40 studies, while one study from June has been removed.SummaryDifference0.8%
- Check72 days agoChange DetectedThe study has expanded to include 39 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
Stay in the know with updates to ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.